Press Releases



Mediclinic Intnl plc - Director/PDMR Shareholding

02/08/2016
RNS Number : 0175G
Mediclinic International PLC
02 August 2016
 

Mediclinic International PLC (the "Company")
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

 

2 August 2016

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITIES ("PDMRs") AND CONNECTED PERSONS

 

This notification is made in accordance with DTR 3.1.4(1).

 

Awards under the Company's Long Term Incentive Plan 2013

 

On 1 August 2016, awards over ordinary shares in Mediclinic International plc were granted to the following PDMR under the rules of the Mediclinic International PLC Long Term Incentive Plan 2013 (the "Plan"):

 

 Name of PDMR

Number of shares in the capital of the Company

 

Petrus Jurgens Myburgh

49, 281

 

GBP Nil consideration per share was paid for the grant of the awards, which are structured as conditional awards.

 

The vesting of an award is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The awards for PDMRs will normally vest on the later of the third anniversary of grant, other than for those PDMRs who also sit on the Board of Directors of Mediclinic International PLC whose awards will vest on the later of the fifth anniversary of grant. The awards will also be linked to the determination of the performance conditions, provided the individual remains an employee or officer of the group. 

 

The Company was informed of the above transactions in London on 1 August 2016.

 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Limited

 

For further information, please contact:

Company Secretary - Capita Company Secretarial Services Limited

Victoria Dalby               +44 (0)207 954 9600


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBBGDIRUGBGLD